Xi Liu
Founder at BEIJING STRONG BIOTECHNOLOGIES,INC.
Net worth: 179 M $ as of 2024-03-30
Profile
Xi Liu founded Beijing Strong Biotechnologies, Inc. in 2001, where he is working as General Manager & Director from 2011.
Dr. Liu also currently works at Fuzhou Maixin Biotech Co., Ltd., as Director from 2020.
Dr. Liu received his graduate degree in 1982 from Harbin Engineering University and doctorate degree in 1988 from Institute of Automation Chinese Academy of Sciences.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2023-06-29 | 50,260,257 ( 19.76% ) | 134 M $ | 2024-03-30 | |
2023-06-29 | 16,753,419 ( 5.01% ) | 45 M $ | 2024-03-30 |
Xi Liu active positions
Companies | Position | Start |
---|---|---|
BEIJING STRONG BIOTECHNOLOGIES,INC. | Founder | 2001-03-28 |
Fuzhou Maixin Biotech Co., Ltd.
Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The private company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Director/Board Member | 2020-09-29 |
Training of Xi Liu
Harbin Engineering University | Graduate Degree |
Institute of Automation Chinese Academy of Sciences | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Fuzhou Maixin Biotech Co., Ltd.
Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The private company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Health Services |
Beijing Strong Biotechnologies, Inc. |
- Stock Market
- Insiders
- Xi Liu